Abbott Laboratories said on Monday it has begun a correction in the United States for certain FreeStyle Libre 3 and FreeStyle ...

The medtech firm plans to launch its next flagship patch-pump in 2027, and its first fully closed loop system for Type 2 ...

UB researchers have published the first comprehensive meta-review of AI-enhanced wearables for people with prediabetes and ...

According to DataM Intelligence, the Insulin Delivery Devices Market Size reached USD 20.26 billion in 2024 and is projected to reach USD 43.11 billion by 2033, growing at a strong CAGR of 8.8% from ...

At age 72, Nathan Harms still climbs ladders, hauls paint cans and balances on beams – tasks that demand precision, stamina ...

The CMS could use its competitive bidding program to address price concerns, after payments for the devices swelled over five ...

Abbott just announced a “medical device correction” for approximately three million glucose sensor monitors in the U.S., ...

The correction is one of the largest in Abbott's recent continuous glucose monitor business, which dominates the global ...

Abbott issued a medical device correction for some of its glucose sensors after internal testing found that some sensors may ...

The pharmaceutical company Abbott has issued a sweeping “medical device correction” affecting around three million of its ...

These healthcare stocks have long-term and profitable growth runways.